Stocks to sell

Acasti Pharma (NASDAQ:ACST) is a classic example of the extreme volatility of small-cap biotech stocks. It was only in late December that the shares were fetching $2.87, up from $1 a year earlier. But now ACST stock is trading around 79 cents, with a market cap of about $70 million. To provide some context, in
0 Comments
Amid the much hyped but ultimately disappointing spate of initial public offerings stands Luckin Coffee (NASDAQ:LK). Unlike names such as Uber (NYSE:UBER) or Lyft (NASDAQ:LYFT), Luckin doesn’t deal with technology per se. Rather, it focuses on delivering a longtime crowd favorite, coffee, to an emerging economic superpower. But has the dramatic enthusiasm for LK stock
0 Comments
Shares of Chinese streaming giant iQiyi (NASDAQ:IQ) have gone parabolic over the past few months, rising from $15 in early October 2019 to $25 by early January 2020. That’s a jaw-dropping 65%-plus rally in IQ stock in just three months. Source: NYC Russ / Shutterstock.com What’s behind the recent strength in the company? More importantly,
0 Comments
At the moment, there aren’t many stocks challenging all-time lows. Obviously, broad market indices sit at all-time highs after a decade-long bull market. Most stocks have done reasonably well in the past few years, and the expectation right now is for more gains as 2020 rolls on. But there’s also the fact that currently challenged
0 Comments
For the first half of 2019, the Cisco (NASDAQ:CSCO) turnaround looked like it was finally going to happen. That is, the legacy tech giant was revamping itself through various cloud, automation, security and collaboration initiatives. Those initiatives were gaining traction, and Cisco’s revenue, margin, and profit growth trends were materially improving. Overall, Cisco stock was
0 Comments
Shares of Acasti Pharma (NASDAQ:ACST) are dropping after the company reported unsuccessful results in a Phase 3 clinical trial for its CaPre drug. CaPre is an omega-3 phospholipid that is under review by the U.S. Food & Drug Administration (FDA) for treating severe hypertriglyceridemia (i.e. high triglyceride levels). Source: Shutterstock Sometimes investing is simple. And
0 Comments
If for nothing else than its dramatic valuation swing, FuelCell Energy (NASDAQ:FCEL) has suddenly become a hot commodity. Since the beginning of November, FCEL stock has jumped almost 700%, easily putting a smile on long embattled shareholders’ faces. But does this alternative energy company have the goods to sustain its resurgence into 2020? Source: Shutterstock
0 Comments
Recognizing that the future of media consumption is online, little-known Indian entertainment company Eros (NYSE:EROS) has tried to aggressively transform from an antiqued film business into a next-gen, hyper-growth streaming content business, something like the Netflix (NASDAQ:NFLX) of India. Source: Shutterstock.com But Eros hasn’t turned into the Netflix of India. Instead, EROS stock has plunged
0 Comments
Bank of America (NYSE:BAC), arguably Warren Buffett’s favorite bank stock, surged 43% in 2019 as investors applauded the bank’s conservative management and better-than-expected quarterly results. Lately, though, the banking sector and Bank of America  stock can’t catch a break. Source: Michael Vi / Shutterstock.com Recent notes to clients from UBS, Baird, and Keefe, Bruyette &
0 Comments